Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral theophylline in stable chronic obstructive pulmonary disease
IRCT138808182685N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of theophylline in chronic obstructive pulmonary disease (COPD), sponsored by Kurdistan University of Medical Sciences. Started Dec 2008; status: completed.
02
Drugs
theophylline
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on IRCT138808182685N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138808182685N1.